Adlon Therapeutics

Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., is a biopharmaceutical company dedicated to developing and providing treatment options for attention deficit hyperactivity disorder (ADHD) and related conditions. Adlon initially focused on adults and adolescents diagnosed with ADHD.